Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03678857
Other study ID # 22261
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 15, 2018
Est. completion date June 1, 2020

Study information

Verified date December 2020
Source Brandon University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Emerging evidence suggests that the timing of creatine supplementation may be an important regulator of muscle growth and strength. It is unclear whether creatine ingested before or after resistance training is more beneficial. A limitation of previous research is the use of a between subject design. A between subject design is associated with several potential confounders (habitual diet, genetics, activities of daily living, etc.) that may have masked the true effect. The purpose of this study is to examine the effect of creatine timing (creatine before vs. creatine after) using a randomized, double blind, repeated measures, within-subject design. Participants will resistance train their left arm and left leg one day and their right arm and right leg the next day. Participants will supplement with creatine BEFORE one of the training days (randomized to either left or right side) and on the opposite training day (opposite side of the body to the previous training day) supplement with creatine AFTER training. Having the same person in both conditions will control for genetics, habitual diet, other daily activities, and so on, that may have confounded previous research. Muscle mass and strength changes will be measured in each limb prior to and following 8 weeks of training to determine whether creatine timing influenced muscle growth. Research Question: To determine whether creatine supplementation timing (i.e., before versus after training) effects 8 weeks of resistance training adaptations (i.e., muscle growth and strength changes).


Description:

Emerging evidence suggests that the timing of creatine supplementation may be an important regulator of muscle growth and strength. It is unclear whether creatine ingested before or after resistance training is more beneficial. A limitation of previous research is the use of a between subject design. A between subject design is associated with several potential confounders (habitual diet, genetics, activities of daily living, etc.) that may have masked the true effect. The purpose of this study is to examine the effect of creatine timing (creatine before vs. creatine after) using a randomized, double blind, repeated measures, within-subject design. Participants will resistance train their left arm and left leg one day and their right arm and right leg the next day. Participants will supplement with creatine BEFORE one of the training days (randomized to either left or right side) and on the opposite training day (opposite side of the body to the previous training day) supplement with creatine AFTER training. Having the same person in both conditions will control for genetics, habitual diet, other daily activities, and so on, that may have confounded previous research. Muscle mass and strength changes will be measured in each limb prior to and following 8 weeks of training to determine whether creatine timing influenced muscle growth. Methods: Day 1 - A 3-day dietary record (to determine typical energy intake and macronutrient breakdown for participant characteristics), anthropometric testing (height and weight), age, muscle thickness (via ultrasound for elbow flexors and leg extensors), and bicep curl and leg extension 1-repetition maximal strength will be determined. In addition, strength training experience and hand dominance will be determined via standardized questionnaires. Muscle thickness of the elbow flexors and leg extensors will be measured before and after the 8 weeks training period using B-mode ultrasound (LOGIQ e BTO8, GE Healthcare, Milwaukee, Wisconsin, USA). Bicep curl and leg extension maximal strength will be assessed on each limb using a 1-repetition maximum (1-RM) standard testing procedure. Briefly, following 5 minutes of cycling on a stationary cycle ergometer, participants will perform 2 warm-up sets (to reduce the risk of injury) in the following order: 1 set of 10 repetitions using a weight determined by each subject to be comfortable and 1 set of 5 repetitions using increased weight. Two minutes after the warm-up sets, weight will be progressively increased for each subsequent 1-repetition maximum attempt with a 2-min rest interval. The 1-rep max will be reached in 4-6 sets, excluding the 2 warm-up sets. All exercise testing will be superivsed by a a trained research assistant or by a Canadian Society for Exericse Physiology certified exercise physiologist. Next 8 Weeks (Resistance Training Program): The Resistance Training will include 3 to 6 sets (progressing overtime; starting at 3 sets and increasing 1 set per week until a maximum of 6 sets) of 80% of 1 repetition maximum with a 3 second eccentric phase (i.e., 1-2 seconds up and 3 seconds down) until failure (unable to complete another repetition or form failure). Each participant will complete 3 training sessions per week per side (total of 6 sessions per week). Prior to each training session, but after the supplement had been consumed, each participant will perform a 5-min stationary cycling warm-up at a self-selected intensity. Resistance exercises will include bicep curls and leg extensions. These two exercises were selected because they are safe and easy to learn and include large upper body and lower body musculature that are known to respond to resistance training. Participants will maintain daily training logs that include the weight, number of sets, and number of repetitions. Supplementation Protocol: Participants will supplement with creatine on one of the training days (either when they are training their left or right side) BEFORE training in a dose previous shown to enhance training adaptations (0.1 grams of creatine per kilogram of body weight before training and a placebo - cornstarch maltodextrin after training). When the participants trains their opposite side of the body they will supplement with creatine AFTER training (0.1 grams per kilogram of placebo before and 0.1 grams per kilogram of creatine after). The placebo will be identical in color, texture, tast, and appearance. The purpose of the placebo is so the participants will not know which day they are receiving creatine before training and which day they are receiving creatine after training. The creatine is research grade and has been independtly tested and will be provided free of charge. Any adverse events related to the exercise or the supplement will be recorded. Post Testing: Following the 8 weeks of training. Participants will complete the baseline testing (Day 1) protocols to determine strength and muscle thickness changes in each limb.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date June 1, 2020
Est. primary completion date June 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: - You may be able to participate in this study if you are between the ages of 18 and 35, are free of disease (e.g., diabetes), do not currently take creatine or other supplements (within the last 12 weeks), and have no known cardiovascular disease or other medical conditions which prevent you from performing physical activity or this type of nutritional supplement. You must also have no other reasons that might make exercise unsafe for you. You will complete a questionnaire (Get Active Questionnaire) to help identify any illness or health concern that could be worsened by performing exercise or make exercise unsafe for you. Exclusion Criteria: - You will not be eligible to participate in this study: 1. If your doctor has informed you that you have a heart condition and should only do physical activity recommended by a doctor. 2. If you feel pain in your chest when you perform any physical activity. 3. If in the past the month you have had chest pain when you were not doing any physical activity. 4. If you lose your balance or consciousness because of dizziness. 5. If you have bone or joint problem (for example, back, knee, or hip) that could be made worse by a change in your physical activity. 6. You have previously had a heart attack or stroke 7. If you know of any other reason why you should not do physical activity. 8. You currently take creatine supplements and/or other "performance enhancing" nutritional supplements

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Creatine
Participants will resistance train their left arm and left leg one day and their right arm and right leg the next day. Participants will supplement with creatine BEFORE one of the training days (randomized to either left or right side) and on the opposite training day (opposite side of the body to the previous training day) supplement with creatine AFTER training. Having the same person in both conditions will control for genetics, habitual diet, other daily activities, and so on, that may have confounded previous research. Muscle mass and strength changes will be measured in each limb prior to and following 8 weeks of training to determine whether creatine timing influenced muscle growth. Research Question: To determine whether creatine supplementation timing (i.e., before versus after training) effects 8 weeks of resistance training adaptations (i.e., muscle growth and strength changes).

Locations

Country Name City State
Canada Brandon University Brandon Manitoba

Sponsors (1)

Lead Sponsor Collaborator
Brandon University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hypertrophy (Muscle thickness will be determined via ultrasound) Muscle thickness will be determined via ultrasound. 8 weeks
Primary Strength (1 repetition maximum will be determined via standard 1RM protocols) 1 repetition maximum will be determined via standard 1RM protocols 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1